| Literature DB >> 31537777 |
Yatao Pang1, Hongling Li1, Long Zhao1, Chunxia Zhang1.
Abstract
BACKGROUND Although survival rates of critically ill patients in Intensive Care Units (ICUs) have improved in recent years, many risk factors cause a few serious complications. This study aimed to evaluate efficacy and safety of comprehensive early rehabilitation therapy for ICU patients. MATERIAL AND METHODS This study recruited ICU patients who were diagnosed as having cerebral hemorrhage or traumatic brain injury. ICU patients were randomly divided into an early rehabilitation therapy group (Observation group, n=21) and a Control group (n=21). Patients in the Control group underwent persistent monitoring of respiratory functions and blood oxygen saturation, as well as electrocardiographic monitoring. ICU patients in the Observation group underwent individualized treatments based on conventional treatments. APACHE II scores, MRC scores, and consciousness improvement rates of ICU patients were evaluated. Incidences of adverse events and complications were also assessed. RESULTS Early rehabilitation therapy significantly decreased APACHE II scores and significantly increased MRC scores compared to the Control group (p<0.05). Early rehabilitation therapy significantly improved consciousness of ICU patients compared to the Control group (p<0.05). Early rehabilitation therapy significantly reduced the incidence of complications compared to the Control group (p<0.05). Early rehabilitation therapy significantly shortened ICU or total hospital stay and mechanical ventilation time compared to the Control group (p<0.05). CONCLUSIONS Early rehabilitation therapy decreased APACHE II scores, enhanced MRC scores, and improved consciousness of ICU patients. Moreover, early rehabilitation therapy also reduced the incidence of complications and shortened ICU or total hospital stay and mechanical ventilation time of ICU patients. Therefore, early rehabilitation therapy was shown to be effective and safe for ICU patients.Entities:
Year: 2019 PMID: 31537777 PMCID: PMC6767950 DOI: 10.12659/MSM.916210
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
General information for the patients in this study.
| Groups | Observe group | Control group | |
|---|---|---|---|
| Cases (n) | 21 | 21 | |
| Age (years, mean ±SD) | 58.48±6.38 | 57.29±6.94 | |
| Gender (n) | Male | 12 | 10 |
| Female | 9 | 11 | |
| APACHE II scores (n, mean ±SD) | 18.00±1.67 | 17.43±1.75 | |
| GCS scores (n, x±s) | 5.67±1.56 | 5.95±1.49 | |
| Course of disease (days, mean ±SD) | 3.90±1.22 | 4.10±1.70 | |
| Tracheotomy cases (n) | 5 | 6 | |
| Operation cases (n) | 13 | 12 | |
| Disease type (n) | Cerebral hemorrhage | 12 | 11 |
| Traumatic brain injury | 9 | 10 | |
APACHEII – acute physiology and chronic health evaluation; GCS – Glasgow coma scale.
Comparison for the APACHE II scores of patients between observation group and control group (mean ±SD).
| Group | Prior treatment | Post treatment |
|---|---|---|
| Observation group (n=21) | 18.00±1.67 | 8.90±2.07 |
| Control group (n=21) | 17.43±1.75 | 10.24±2.19 |
p<0.05 vs. prior treatment within group,
p<0.05 vs. effects of post treatment in control group.
APACHEII – acute physiology and chronic health evaluation.
Comparison for the MRC scores of patients between observation group and control group (mean ±SD).
| Group | Prior treatment | Post treatment |
|---|---|---|
| Observation group (n=21) | 47.14±1.85 | 52.95±3.99 |
| Control group (n=21) | 46.38±1.88 | 50.10±4.21 |
p<0.05 vs. prior treatment within group;
p<0.05 vs. effects of post treatment in control group.
MRC – medical research council.
Comparison for the therapeutic effects of patients between observe group and control group (%).
| Groups | Basic cure | Markedly effective | Effective | Total |
|---|---|---|---|---|
| Observe group (n=21) | 5 (24%) | 10 (48%) | 3 (14%) | 18 (86%) |
| Control group (n=21) | 2 (9.5%) | 5 (24%) | 9 (43%) | 16 (76%) |
p<0.05 vs. control group.
GCS – Glasgow coma scale.
Comparison for the ratios of complications in patients between observation group and control group (%).
| Groups | ICU-AW | Pneumonia | Deep venous thrombosis | Total |
|---|---|---|---|---|
| Observation group (n=21) | 1 (4.8%) | 1 (4.8%) | 2 (9.5%) | 4 (19%) |
| Control group (n=21) | 3 (14%) | 3 (14%) | 3 (14%) | 9 (43%) |
p<0.05 vs. control group.
ICU-AW – Intensive Care Unit acquired weakness.
Comparison for the ICU hospital stay, total hospital stay and mechanical ventilation time in patients between observe group and control group (mean ±SD).
| Groups | ICU hospital stay (days) | Total hospital stay (days) | Mechanical ventilation time (days) |
|---|---|---|---|
| Observation group (n=21) | 11.76±2.63 | 31.38±4.006 | 3.00±0.71 |
| Control group (n=21) | 14.00±2.19 | 35.24±5.059 | 5.17±0.75 |
p<0.05 vs. control group.
ICU – Intensive Care Unit.